(Reuters) – Drug makers Gilead Sciences Inc and Merck & Co Inc are collaborating to develop a long-acting HIV therapy, the Wall Street Journal reported on Monday.
(Reporting By Mrinalika Roy in Bengaluru; Editing by Shounak Dasgupta)
Gilead, Merck collaborate to develop HIV treatment – WSJ
Mar 15, 2021 | 5:32 AM
